Decrease in the prevalence of IL-4-producing CD4+ T cells in patients with advanced stage of primary biliary...

Area of Science:

• Immunology
• Hepatology
• Cellular Biology

Background:

• Primary biliary cirrhosis (PBC) is a chronic liver disease with complex immunological underpinnings.
• Understanding the balance of CD4+ T cell subsets is crucial for elucidating PBC pathogenesis.
• Distinguishing immunological profiles in symptomatic (sPBC) versus asymptomatic (aPBC) patients may reveal disease-specific immune responses.

Purpose of the Study:

• To investigate the relative prevalence of CD4+ T cell subsets (Th1, Th2, Th0) in symptomatic and asymptomatic PBC patients.
• To correlate these immunological findings with the histological stage of PBC.
• To elucidate the immunological features associated with disease severity in PBC.

Main Methods:

• Analysis of peripheral blood mononuclear cells from 24 PBC patients (9 sPBC, 15 aPBC) using intracellular cytokine staining.
• Quantification of gamma-interferon (IFN-γ)-producing Th1 cells, interleukin-4 (IL-4)-producing Th2 cells, and dual producers (Th0).
• Comparison of T cell subset prevalence with age-matched healthy controls and patients with chronic hepatitis C or secondary cirrhosis using flow cytometry (FACScan).

Main Results:

• A significant decline in Th2 cell prevalence was observed in sPBC patients compared to healthy controls and aPBC patients (p < 0.05).
• No significant difference in Th1 or Th0 cell prevalence was noted between sPBC and aPBC groups.
• Histological analysis revealed that aPBC patients were in early stages (I-II), while most sPBC patients were in advanced stages (III-IV).

Conclusions:

• Advanced stage PBC is characterized by a significant decrease in Th2 cell prevalence.
• A potential shift towards Th1 predominance may occur in advanced PBC, correlating with disease progression.
• Immunological profiling of T cell subsets offers insights into PBC pathogenesis and disease staging.